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ABSTRACT
Introduction: The case definition of influenza-like illness (ILI) is a powerful epidemiological 
tool during influenza epidemics. Methods: A prospective cohort study was conducted to 
evaluate the impact of two definitions used as epidemiological tools, in adults and children, 
during the influenza A H1N1 epidemic. Patients were included if they had upper respiratory 
samples tested for influenza by real-time reverse transcriptase polymerase chain reaction 
during two periods, using the ILI definition (coughing + temperature ≥ 38oC) in period 
1, and the definition of severe acute respiratory infection (ARS) (coughing + temperature 
≥ 38oC and dyspnoea) in period 2. Results: The study included 366 adults and 147 children, 
covering 243 cases of ILI and 270 cases of ARS. Laboratory confirmed cases of influenza were 
higher in adults (50%) than in children (21.6%) ( p < 0.0001) and influenza infection was 
more prevalent in the ILI definition (53%) than ARS (24.4%)  (p < 0.0001). Adults reported 
more chills and myalgia than children (p = 0.0001). Oseltamivir was administered in 58% and 
46% of adults and children with influenza A H1N1, respectively. The influenza A H1N1 case 
fatality rate was 7% in adults and 8.3% in children. The mean time from onset of illness until 
antiviral administration was 4 days. Conclusions: The modification of ILI to ARS definition 
resulted in less accuracy in influenza diagnosis and did not improve the appropriate time and 
use of antiviral medication.
Keywords: Seasonal influenza. Influenza A H1N1. Epidemiological surveillance. Influenza-
like illness. Acute respiratory syndrome.
RESUMO
Introdução: A definição de síndrome gripal é uma ferramenta epidemiológica importante 
durante epidemias de influenza. Métodos: Foi conduzido estudo de coorte prospectivo para 
avaliar o impacto das definições de síndrome gripal (SG) e doença respiratória aguda grave 
(DRAG) como ferramenta de vigilância epidemiológica, em adultos e crianças, durante a 
epidemia de influenza A H1N1. Os pacientes foram incluídos se tivessem coleta de secreção 
respiratória alta testada por PCR real time para o vírus da influenza. Os dados clínicos e 
epidemiológicos foram estudados comparando-se dois períodos: período 1: SG (tosse + 
temperatura ≥ 38oC), e período 2: DRAG (tosse + temperatura ≥ 38 e dispnéia). Resultados: 
Foram incluídos 366 adultos e 147 crianças, em um total de 243 casos de SG e 270 DRAG. 
A confirmação laboratorial de influenza em adultos (50%) foi significativamente maior do 
que em crianças (21,6%) (p < 0,0001) e a definição de SG foi mais confirmatória de infecção 
por influenza (53%) do que DRAG (24,4%) (p < 0,0001). Adultos referiam mais calafrios e 
mialgias do que as crianças (p = 0,0001). Oseltamivir foi prescrito, respectivamente, em 58% 
e 46% dos adultos e crianças com influenza A H1N1. A letalidade por influenza A H1N1 foi 
de 7% em adultos e 8,3% em crianças. Conclusões: A mudança de definição do critério de 
vigilância epidemiologia de SG para DRAG resultou em redução significativa da acurácia do 
diagnóstico de influenza e não contribuiu para melhor  indicação do antiviral como também 
para a sua prescrição no tempo apropriado.
Palavras-chaves: Influenza sazonal. Influenza A H1N1. Vigilância epidemiológica. Síndrome 
gripal. Síndrome respiratória aguda.
A novel influenza A (H1N1) virus of swine 
origin spread worldwide in 2009, causing the first 
influenza pandemic of the 21st century1-4. Unlike the 
situation in the Northern hemisphere, in Brazil the 
peak of the influenza season begins in late autumn 
(May) to early spring (September). From a public 
heath perspective, the case definition of influenza-
like illness (ILI) is the most important surveillance 
tool for identifying influenza cases and other 
respiratory diseases. ILI definitions can improve 
individual case management, given the availability 
of safe and effective anti-influenza drugs and increase 
wider public health surveillance and mitigation 
measures. The clinical diagnosis of influenza is 
nonspecific. The use of symptoms complex for ILI 
in the public healthcare system can be predictive 
of influenza infection, especially in the setting of 
a community outbreak. However, the sensitivity 
and positive predictive value of ILI definition may 
vary according to the prevalence of the disease, the 
geographic area and the affected population.
The first laboratory-confirmed case of influenza 
A H1N1 in Brazil occurred on May 7th, 2009, and 
on July 16th, 2009 the Ministry of Health declared 
the sustained transmission of the virus5. Brazil 
was seriously affected by the H1N1 pandemic 
with a reported case-fatality rate of 11.2% among 
confirmed pandemic influenza5.
The purpose of this study was to analyze 
the clinical presentations and the laboratory 
confirmation of influenza infections during the 
influenza A H1N1 epidemic, based on ILI and severe 
acute respiratory syndrome (SARS) definitions that 
required mandatory reporting to the public health 
care system, performed at the Hospital and Clinics of 
the State University of Campinas (HC-UNICAMP), 
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TABLE 1 - Distribution of the 513 reported cases of ILI and SARS in adults and children, according to the laboratory results (RT-PCR) for influenza, in 
the two different periods. 
 
 AD CH AD CH AD CH AD CH
 AD CH n % n % n % n % n % n % n % n %
Period 1 (ILI)* 193 50 72 37.3 12 24.0 35 18.0 9 18.0 107 55.4 21 42.0 - - - -
Period 2 (SARS)** 173 97 43 24.8 12 12.3 11 6.3 0 0.0 54 31.0 12 12.3 16 9.2 4 4.1
Total 366 147 115 31.4 24 16.3 46 12.5 9 6.1 161 43.9 33 22.4 16 4.4 4 2.7
Period 1: 04/24 to 07/15/2009, period 2: 07/16 to 12/31/2009, AD: adult (>15 years old), CH: children (<14 years old). ILI: influenza-like illness, SARS: severe 
acute respiratory syndrome, RT-PCR: reverse transcription polymerase chain reaction. 
*Laboratory-confirmed cases of influenza infection (influenza A (H1N1) + seasonal) was higher in period 1 (p < 0.0001). 
**Laboratory-confirmed cases of influenza A (H1N1) was higher in period 1 (p = 0.0002). 
p < 0.0001 (for comparing the total number of laboratory-confirmed cases of influenza infections in children vs. adults).
Number of 
reported cases
Influenza A (H1N1) Seasonal influenza
Total number of confirmed
cases of influenza infections Number of deaths
The study was conducted at HC-UNICAMP, a 400-bed tertiary-
care university hospital that provides all major medical services as the 
reference hospital for 5 million inhabitants, except for gynecology-
obstetrics cases and neonates. HC-UNICAMP participated as one 
of the reference hospitals for assisting the severe cases of influenza A 
H1N1 cases for 42 cities located in the surrounding geographic area. 
The study included all patients attended from April 28th to 
December 31st, 2009, whose case were identified as mandatory 
notification for ILI or ARS and for which swab samples from the 
upper respiratory tract were tested for  real-time reverse transcriptase 
polymerase chain reaction (RT-PCR) for influenza. The hospital 
communicable surveillance team performed all the mandatory 
notifications. Influenza infections (influenza A H1N1 and seasonal 
influenza type A and B) were confirmed by RT-PCR, which was 
performed by the reference microbiology laboratory of the State of 
São Paulo (Adolfo Lutz Institute). 
To analyze the mandatory notifications, this study was divided 
in two periods: period 1 from April 28th to July 15th and period 2 
from July 16th to December 31st, 2009. During 2009, the Ministry 
of Health of Brazil established different protocols for managing 
the surveillance of and assistance for patients with influenza. 
In period 1, the government established a containment plan that 
consisted of mandatory notification, combined swab of nasal 
and throat for the molecular diagnosis of influenza by RT-PCR, 
and treatment with oseltamivir of all cases with the following 
ILI definition: acute respiratory disease + temperature ≥ 38oC + 
coughing, and returning from countries where influenza A H1N1 
was established or individuals in direct contact with a confirmed 
case of influenza A H1N1. During period 2, ARS was defined as 
acute respiratory disease + fever ≥ 38oC + coughing and dyspnoea. 
All suspected cases of influenza with mild symptoms were attended 
in the primary or secondary healthcare systems and only the severe 
cases or patients with risk factors for complications of influenza were 
referred to our hospital.
Patients were evaluated for the presence of underlying conditions, 
outcome and the following clinical symptoms: fever ≥ 38oC, 
coughing, chills, dyspnea, sore throat, arthralgia, myalgia, nasal 
congestion, diarrhea, hospitalization and use of oseltamivir. The 
data were analyzed according to age (child < 15 years-old; adult ≥ 
15-years-old) and the laboratorial RT-PCR result for influenza A 
H1N1, seasonal influenza, or influenza-negative cases.
Statistical analysis
Statistical analysis was performed using Epi Info (version 
3.5.1, 2008; CDC, Atlanta, USA) software. Normally distributed 
continuous variables were analyzed by the Student t test or analysis 
of variance. For comparison of length of stay and age data, the 
nonparametric Mann-Whitney and Kruskal-Wallis methods were 
used. The X2 test or Fisher exact test were used to compare categorical 
variables between groups and to test for heterogeneity among 
multiple proportions. For data that were not normally distributed, 
the Wilcoxon rank-sum test for continuous variables was used. A 
two-tailed p value of < 0.05 was considered statistically significant.
Considering the total period of study, 513 patients composed 
the study population; these patients consisted of 366 (71%) adults 
and 147 (29%) children. Influenza infections (influenza A (H1N1) 
+ seasonal influenza) were confirmed in 161 (43.9%) adults and 
in 33 (22.4%) children. Influenza A (H1N1) was confirmed in 24 
(16.3%) children and in 115 (31.4%) adults; 9 children and 46 adults 
presented seasonal influenza and the remaining population were 
negative for influenza infections (Table 1). 
The number of confirmed cases of influenza infections differed 
according to each period of analysis, in adults and children. In period 
1 (ILI), 107 (55.4%) of the 193 reported cases in adults and, 21 
(42%) out of the 50 reported cases in children confirmed influenza 
infection. In period 2 (SARS), among 173 adults, only 54 (31%) 
were confirmed with influenza infection. Ninety-seven children were 
reported in period 2, 12 (12.3%) were confirmed with influenza 
infection and all 12 confirmed cases were influenza A (H1N1) 
(Table 1). The total number of confirmed cases of influenza 
infections, in adults (107 cases) + children (21 cases), was 
significantly higher in period 1, than in period 2 (54 cases in adults 
+ 12 cases in children) (p < 0.0001) (Table 1), suggesting that the 
ILI definitions were significantly more confirmatory for influenza 
infection than SARS. Laboratorial confirmation of influenza infection 
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TABLE 2 - Comorbidities associated with influenza A (H1N1), seasonal influenza, and influenza-negative groups of patients.
 Children (0 to ≤ 14 years old) Adult (≥ 15 years old)
 n(%) n(%)
 Influenza Seasonal Influenza   Influenza Seasonal Influenza
 A (H1N1) influenza negative  A (H1N1) influenza negative
 n = 24 n = 9 n = 114 Total n =115  n  = 46 n = 205 Total
 (16.3) (6.1)  (77.5)  n = 147  (31.4)   (12.5)  (56)  n = 366
Mean age (years old) 5.45 ±4.9 4.9±5.3 3.1±4 3.6±4.3 33.13±11.82 39.4±14.9 39.89±17.9 37.7±16.1
Gender male 13 (41.6) 4 (44.4) 61 (53.5) 78 (53.0) 55 (47.8) 25 (54.3) 84 (41.0) 164 (44.8)
Comorbidities*  
absence 12 (50.0) 5 (55.5) 27 (23.7) 44 (30.0) 78(67.8) 28(60.8) 104 (50.7) 210 (57.4)
age <2 years old (without comorbidity) 7 (29.1) 3 (33.3) 37 (32.4) 47 (32.9)    
age >65 years (without comorbidity)     0 (0.0) 0 (0.0) 2 (0.9) 2 (0.5)
lung disorder 1 (4.1) 1 (11.0) 28 (2.5) 30 (2.0) 7 (6.0) 5 (10.8) 21 (10.2) 33 (9.0)
cardiovascular disease 1 (4.1)  4 (3.5) 5 (3.4) 6 (5.2) 2 (4.3) 18 (8.7) 26 (7.1)
neurologic condition 2 (8.2)  6 (5.2) 8 (5.4)  2 (4.3) 2 (1.0) 4 (1.0)
renal disease 1 (4.1)  3 (2.6) 4 (2.7) 1 (0.8) 1 (2.1) 1 (0.5) 3 (0.8)
HIV (+)   1 (0.9) 1 (0.7) 1 (0.8)  9 (4.4) 10 (2.7)
metabolic or endocrinal disorder     7 (6) 3 (6.5) 14 (6.8) 24 (6.5)
morbid obesity      5 (4.3)  4 (2.0) 9 (2.4)
hematological malignancy   2 (1.7) 2 (1.3) 5 (4.3)  12 (5.8) 17 (4.6)
SOT     3 (2.6) 1 (2.1) 5 (2.4) 9 (2.4)
smoking      6 (5.2) 3 (6.5) 5 (2.4) 14 (3.8)
others   6 (5.2) 6 (4.0) 2 (1.7) 1 (2.1) 12 (5.8) 15 (4.0)
Total of comorbidities  12 (50.0) 4 (44.4) 87 (76.3) 103 (70.0) 43 (37.3) 18 (39.0) 105 (51.0) 166 (45.3)
*Lung disorder: asthma, chronic obstructive pulmonary disease COPD, cystic fibrosis; Cardiovascular disease: congestive heart failure or atherosclerotic disease, hypertension; 
Neurologic condition: neuromuscular, neurocognitive, seizure disorders; Renal disease: renal dialysis, chronic renal insufficiency; Metabolic or endocrinal disorders: diabetes, 
thyroid disorders; SOT: solid organ transplant (kidney, liver). 
was significantly higher among adults (164/362; 50%) than among 
children (32/148; 21.6%) in both periods. (p < 0.0001) (Table1). 
Considering the child population of both periods, the mean 
age was 5.45, 4.9 and 3.1 years-old for influenza A H1N1, seasonal 
influenza and influenza-negatives cases, respectively, and influenza 
A H1N1 was more prevalent in older children (p = 0.03). Seventy-
five children were < 2 years-old and 72 children were > 2 years-old. 
Children < 2 years-old were more likely to present influenza-negative 
results (84%) than those > 2 years-old (70.8%) (p = 0.04). Twenty-
four (16.3%) cases of influenza A H1N1 and 9 (6.1%) cases of 
seasonal influenza were confirmed among the 147 notifications that 
comprised the total child population (Table 1).
In the adult population, influenza A H1N1 was significantly 
more prevalent in younger adults (mean age 33.13; ±11.8 years-
old) than seasonal influenza (39.4; ±14.9) and the negative groups 
(39.89; ±17.9) (p = 0.001). Laboratory confirmation of influenza 
infections was significantly higher in period 1 (55.4%; 107cases/193 
notifications) than in period 2 (31.2%; 54 cases/173 notifications) 
(p < 0.0001) (Table 1).
The hospitalization of adults and children occurred 
predominantly in period 2 (adults: 139/173 (80.4%); children: 
95/97 (98%)) compared with period 1 (adults: 13/193 (6.7%); 
children: 4/50(8%)) (p < 0.0001). In period 2, the mean time of 
hospitalization was significantly higher in children (14.3 ±25 days) 
than in adults (6.9 ±8.6 days) (p = 0.0009). 
Comorbidities
Forty-four (30%) children presented no comorbidities. 
Lung disorders were present in 30 (20.4%) children, followed 
by neurological conditions in 8, and cardiovascular, renal, and 
hematological diseases in 8, 4, and 2 children, respectively 
(Table 2). Of note, 28 of the 30 children in the influenza-negative 
group presented lung diseases. Forty-seven children were ≤ 2 years-
old. Considering the proportion of children with comorbidities in 
the influenza negative group and in the influenza infection groups 
(influenza A(H1N1) + seasonal influenza), the influenza-negative 
group presented 1.6 times more comorbidities than children with 
influenza infections, reflecting the severity of the cases. 
In the adult population, 57.4% of the cases presented no 
comorbidities. Similar to the child population, the influenza-negative 
group presented 1.5 times more comorbidities than the influenza 
patients. Lung disorders were the main underlying disease in the 
three groups of patients followed by cardiovascular and metabolic 
diseases (Table 2).
Clinical symptoms 
The following symptoms: fever, coughing and dyspnea, which 
composed the clinical definitions of ILI and SARS, were not 
included in the analysis of clinical symptoms. Adults with influenza 
A H1N1 reported chills more frequently (40%) than children (4.2%) 
(p = 0.0001). Reports of myalgia were also significantly greater in 































































































































































































































































































































































































     
    
    













































































































    
    
    
    
    









     
    
    
































































































     
    
    
    
    










     
    
    
    











     
    
    






















































































































































































































    
    
    
   
 
    
    
    











    
    
    











     
    
    






























































































































a sore throat occurred significantly more often 
in influenza-negative adults than in influenza-
negative children (p = 0.0001). Children with 
influenza A H1N1 presented myalgia more 
frequently (25%; p = 0.008) than the other 
groups of children (Table 3). 
The mean time between illness onset 
and nasopharyngeal swabs was higher in the 
influenza-negative patients (3.3 days; SD 2.5) 
than in influenza A H1N1 (2.5 days; SD 2) and 
seasonal influenza patients (2.8 days; SD 3) 
(p = 0.0005).
The use of oseltamivir in the adult and 
child populations was 57.8% and 45.8% in 
cases of influenza A H1N1, 43.5% and 22% 
in the cases of seasonal influenza, and 54.1% 
and 54% in the negative patients, respectively 
(p = 0.10) (Table 3).
Outcome
In this study population, 16 (4.4%) adults 
and 4 (2.7%) children died. Influenza A 
H1N1 was responsible for 8 (6.9%) deaths 
among 115 cases in adults and for 2 (8.3%) 
deaths in 24 cases in children. One (2.2%) 
in 46 cases in adults died due to seasonal 
influenza. In the influenza-negative group, 
7 adults and 2 children died (Table 4). 
In the adults (8 cases) who died due to 
influenza A H1N1, only 5 (62.5%) received 
oseltamivir in a mean period of 3 days (0-7 
days) from illness onset; comorbidities were 
verified in 7 (87.5%) patients. The time 
of hospitalization for adults who died of 
influenza A H1N1 was shorter (4.75; ± 6.8 
days) than that of patients who died in the 
influenza-negative group (12.6 ± 7.5 days) 
(p = 0.02). One child died of influenza A H1N1, 
13 days after hospitalization and received 
oseltamivir 12 days after onset (Table 4).
When the patients who died were com-
pared with those who survived, the fatal 
outcomes were not related to the mean time of 
illness onset until medical assistance (death-2.8 
days; cure-2.3 days; p = 0.5) and to the mean 
time of illness onset until the administration 
of oseltamivir (death-4 days; cure-4.9 days; 
p = 0.85); however, the proper time of 
oseltamivir administration was inadequate. 
Of note, 90% of the patients who died due to 
influenza A H1N1 presented comorbidities 
compared with 31% of those with a favorable 
outcome (p = 0.0003).
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TABLE 4 - Characteristics of the adults and children with fatal outcome.
     Mean days between Number of    
 Mean age Use of  onset and use of  patients with  Duration of hospital stay  Comorbidities
 (years)(SD) oseltamivir oseltamivir comorbidities (in days) (n of patients) 
Adult (n=16)
Influenza A H1N1 (n=8) 40 (±15) 5 (62.5%) 3 (0 to 7 days) 7 (87.5%) 4.75 (±6.8) obesity (2)
     (range 0 to 18) endocrinal disorder(1)
      lung disease (2)
      hematological
      malignancy (2)
      
Influenza negative(n=7) 52 (±18) 4 (57.1%) 11  12.6 (±7.5) cardiovascular (2)
    (range 1 to 2days) 6 (85.7%) (range 1 to 20) liver transplant (1)
      neurological disorder (1)
      obesity (1)
      lung disease (1)
Children (n=4)
Influenza A (H1N1) (n=2)
child 1 0 Yes 12 days 1 13 < 2 years old
child 2 2 Yes 1 day 1 3 neurological disorder
Influenza negative (n=2)
child 1 0 Yes 1 day 1 0 < 2 years old+ neurological
      disorder
child 2 10 Yes 58 days 1 77 neurological disorder
SD: Standard deviation.
DISCUSSION
The definitions of ILI vary according to the epidemiological 
situation and public healthcare system policies, such as the sentinel 
programs, institutions and geographic areas. The impact of ILI 
definitions seemed to be of major importance during the influenza A 
H1N1 epidemic in our region. Many physicians diagnosed influenza 
infections based on the presence or absence of certain clinical 
symptoms and signs. Previous reports have indicated that during 
the influenza season, physicians can correctly diagnose the infection 
in 60% to 70% of cases on the basis of clinical symptoms alone6,7.
In this study, two definitions were used during the two different 
periods, and they were directly correlated with the diagnosis of 
influenza infections. The ILI definition adopted in period 1 was 
significantly more predictive of influenza infections than that used 
in period 2. Laboratorial influenza confirmations (43.9%) were 
greater in the adult population than in the child population (22.4%) 
in both periods. Analysis of the data showed, however, that influenza 
infection was confirmed in 37.8% of the study population (513 
notifications) compared to 16.7% of 34,506 notifications reported 
by the official data of the surveillance team of the Ministry of Health5, 
suggesting that our team might have been stricter with the clinical 
definitions of ILI and ILI+ARS.
Previous studies have shown that the clinical presentation of 
the novel H1N1 (2009) in adults8-10 and children11 does not differ 
significantly from that of contemporary seasonal influenza. In our 
adult population, the clinical presentation of the patients with 
laboratory-confirmed influenza infections (161; 50%) was similar to 
that of the influenza-negative patients (Table 4), but was different 
from that of children with influenza infections and the influenza-
negative group. Myalgia and chills were reported significantly more 
often by adults with influenza than children. The clinical presentation 
of influenza may differ from hospitalized adults to outpatients12, 
and this might explain the high number of influenza-negative 
cases in our hospitalized patients with ILI+ARS symptoms. The 
influenza-negative adults and children presented significantly more 
comorbidities than did patients with influenza infections. This fact 
probably led to the increased number of hospitalizations and suspected 
diagnoses of influenza during the 2009 pandemic influenza season.
Analysis of the data showed that the number of influenza-negative 
results was significantly higher in children ≤ 2 years-old (64%) than 
in children > 3 years-old (p = 0.04), suggesting that some other virus 
might have caused ILI13. In cases involving children, clinical signs and 
symptoms needed to be precisely collected from the child’s mother. 
Among older children, coughing and fever together are known to have 
a positive predictive value of 79%8, while a better definition needs to 
be designed and validated for younger children. 
Defining the clinical predictors of influenza infection can help 
guide timely therapy and avoid unnecessary antibiotic use. During the 
influenza season, patients with ILI who present both coughing and 
fever >38oC within 48h of symptom onset are likely to have influenza 
and it may be appropriate to consider the administration of influenza 
antiviral therapy. In our study population, oseltamivir was prescribed 
similarly for adults and children against influenza A H1N1, seasonal 
influenza and influenza-negative patients, such that about 50% of the 
influenza-negative cases unnecessarily took oseltamivir. 
At the early stages of the epidemic, the worldwide stock of 
oseltamivir distributed among countries was short. Brazil controlled 
the distribution of the antiviral, making it available only to patients 
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Seasonal influenza (n=1) 69 1 1 day 1 (100%) 26 > 65 years-old
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with ILI coming from countries where cases of influenza A H1N1 
had been reported. After the Brazilian Ministry of Health declared 
the sustained transmission of the virus, oseltamivir was restricted to 
patients with ARS or with comorbidities, and the distribution of the 
drug occurred only at reference centers, such as our hospital, and the 
drug was not available for purchase in pharmacies. The restriction 
of oseltamivir to severe cases may have led doctors to include and 
notify a high number of cases that did not correctly correspond to 
the definitions and to sample nasopharynx secretions for influenza 
A H1N1 PCR test, so they could offer oseltamivir to their patients. 
The overall case fatality rate in the symptomatic population 
with influenza A H1N1 was surprisingly high in adults (6.9%) and 
in children (8.3%). Data in the literature reported an overall range 
of estimates from 0.0004% to 1.47%14. The case fatality rate for 
symptomatic illness was estimated to be 0.048% in the United States15 
and 0.026% in the United Kingdom16. In Mexico17, the general fatality 
rate was reported as 1.3 per 100 confirmed cases; in Argentina it was 
2%18. Our hospital is a tertiary care reference hospital servicing the 
100km surrounding area population (5 million inhabitants), such 
that patients with severe diseases were referred to our hospital for 
diagnosis and medical assistance. This might partly explain the high 
case fatality rate in population attended. 
Recommendations have been made to start empirical antivirals 
to patients with suspected influenza A H1N1, and not to withhold 
the same because of a negative PCR result or delay treatment until 
RT-PCR results are available19. RT-PCR is known to be positive in 
81% of cases20 and the optimal clinical specimen for identification of 
the virus varies according to several factors, such as the concentration 
and duration of viral shedding21, the specimen source and quality, 
the sensitivity of the test, etc. In our patients the mean time from 
illness onset until the nasopharyngeal swabs was higher in the 
influenza-negative group (3.3 ± 2.5days) than in influenza A H1N1 
(2.5 ± 2 days) and seasonal influenza patients (2.8 ± 3 days) 
(p=0.005), suggesting that the delay in time to collect the swabs 
might have reduced the sensitivity of the RT-PCR and cases of 
influenza A H1N1 were misdiagnosed in the influenza-negative group. 
Although Brazil is a tropical country, the State of São Paulo 
has milder temperatures and a stronger winter compared with the 
Northern, Northeaster and Central-Western regions of the country. 
State of São Paulo and Southern regions were seriously affected by the 
pandemic A (H1N1) influenza virus, exhibiting high attack rates and 
higher case fatality rates than those of countries from the Northern 
hemisphere. To study the clinical presentations and outcome of a new 
influenza virus was a major issue; it allowed us to better understand 
the epidemiology of the disease and to recognize that influenza 
can represent a very important public health disease, causing fatal 
outcomes in children and adults in tropical and subtropical countries. 
Of note, except for healthcare workers exposed to potentially 
infective biological samples housing the influenza A H1N1 virus, the 
Ministry of Heath did not recommend antiviral chemoprophylaxis. 
The initial declarations of WHO stating that fatality rates of influenza 
A H1N1 were similar to those of the seasonal influenza virus might 
have influenced healthcare workers and the public in general to under 
evaluate the real risk of the epidemic, especially in tropical countries. 
Further studies showed that the new virus differs in modest but subtle 
ways from seasonal H1N1 virus in its intrinsic virulence for humans, 
which is in agreement with the epidemiology of the pandemic to 
date22. Pathological evaluation of respiratory specimens from initial 
influenza-associated deaths suggested marked differences in viral 
tropism and tissue damage compared with seasonal influenza23. These 
findings are therefore relevant for understanding the transmission 
and therapy.
In conclusion, analysis of the data obtained in this work showed 
that, during the influenza A H1N1 epidemic, the definitions of ILI 
symptoms directly determined the medical assistance provided 
to the patients. Modifying the clinical symptoms of ILI to ARS to 
include patients with dyspnea resulted in the notification of a high 
proportion of influenza-negative patients and to an unexpected 
number of patients with confirmed influenza infections who did 
not receive appropriate antiviral therapy. The high case fatality rate 
in our study was multifactorial, including the referral of patients with 
severe comorbidities to our hospital and the delay in diagnosis and 
antiviral administration. This epidemic changed the paradigm of 
the influenza infection representing a commonplace viral infection, 
affecting the elderly, patients with immunosuppressant conditions or 
lung disorders, to an infection with high rates of case fatality. 
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